VCA Antech Sees Same-Store Revenue Drop By 2.2% In Q1



Published:

VCA Antech Inc.’s animal division reported revenue of $269.9 million for its first quarter ended March 31, compared to revenue of $246.7 million in the year-ago period. The 9.4 percent increase was driven by acquisitions made in the past 12 months, said Bob Antin, chairman and CEO of the company.

VCA Antech’s same-store revenue declined by 2.2 percent while its same-store gross profit margin declined to 14.9 percent from 16.9 percent, according to Antin.
During the quarter, VCA Antech acquired two animal hospitals which had historical combined annual revenue of $4.8 million.

VCA Antech’s laboratory division reported revenue of $79.5 million for its first quarter, compared to revenue of $78.2 million in the year-ago period.

The medical technology division reported revenue of $19.1 million for its first quarter, compared to revenue of $15.8 million in the year-ago period.

Overall, the Los Angeles-based company reported net income of $30.5 million on revenue of $355.1 million for the first quarter, compared to net income of $32.9 million on revenue of $330.7 million in the year-ago period.

VCA Antech reaffirmed its fiscal year 2011 guidance: revenue from $1.47 billion to $1.51 billion and net income from $124.1 million to $132.8 million.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Wildlife, Exotic Animal Medicine Symposium to be Held in April

The symposium will be held at the University of California, Davis.

Interceptor Heartworm Drug Returns Under Elanco

Discontinued by Novartis, Interceptor should be available this spring under new owner Elanco.

Idexx Unveils Kidney Test Breakthrough

A test being added to Idexx profiles may identify the onset of kidney disease about 17 months sooner in cats and dogs.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module